GlassScriptPhysician profile
Sheryl M Handler
NPI 1245217587
$1,016.95
in general payments reported to CMS, 2019-2025
10 companies · $218 in 2025
The $218 reported for 2025 was more than what a typical Pediatric Ophthalmology and Strabismus Specialist provider received nationally (typical 2025 total: $118).
See the full distribution for Pediatric Ophthalmology and Strabismus Specialist
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $221 · 2020: $17.24 · 2021: $12.89 · 2022: $160 · 2023: $167 · 2024: $221 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $606.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $605.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $221.86 | 2024-2025 | Dupixent |
| Merck Sharp & Dohme LLC | $186.71 | 2023-2025 | Enflonsia, Vaxneuvance |
| Tris Pharma INC | $154.43 | 2019-2023 | Dyanavel Xr, Quillivant, Quillichew Er |
| Silk Road Medical, INC. | $147.15 | 2019 | |
| Novo Nordisk INC | $116.98 | 2024 | Wegovy |
| Glaxosmithkline, LLC. | $88.48 | 2022 | |
| Glaukos Corporation | $70.38 | 2022 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Horizon Therapeutics Plc | $12.89 | 2021 | |
| Travere Therapeutics, INC. | $0.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheryl Handler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.